Targeted bacteriophage therapy alleviates enteroaggregative Escherichia coli–associated renal injury in diabetic kidney disease
hLife
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
Targeted bacteriophage therapy alleviates enteroaggregative Escherichia coli–associated renal injury in diabetic kidney disease. // hLife. – URL: https://www.sciencedirect.com/science/article/pii/S2949928326000647?dgcid=rss_sd_all
Targeted bacteriophage therapy alleviates enteroaggregative Escherichia coli–associated renal injury in diabetic kidney disease. hLife. https://www.sciencedirect.com/science/article/pii/S2949928326000647?dgcid=rss_sd_all
“Targeted bacteriophage therapy alleviates enteroaggregative Escherichia coli–associated renal injury in diabetic kidney disease.” hLife.
@article{article3683,
title = {Targeted bacteriophage therapy alleviates enteroaggregative Escherichia coli–associated renal injury in diabetic kidney disease},
journal = {hLife},
url = {https://www.sciencedirect.com/science/article/pii/S2949928326000647?dgcid=rss_sd_all}
}